Google快讯 - lung cancer

	lung cancer 实时更新 ⋅ 2026年1月28日
	新闻
	A Canadian Perspective on Perioperative Systemic Therapy in Resectable Non-Small Cell ... PubMed The management strategies in resectable non-small cell lung cancer (NSCLC) have changed over the last few years. Despite advancements in surgical ... 标记为不相关
	Blood test helps early lung cancer detection - Chinadaily.com.cn China Daily "Distinguishing benign from malignant nodules is the key to achieving earlier lung cancer diagnosis and lowering mortality," said Hu Hai, a professor ... 标记为不相关
	Coverage gaps remain for lung cancer patients beyond the second line with limited treatment options Managed Healthcare Executive Patients who have progressed through three or more lines of therapy and harbor a BRAF V600E mutation may still benefit from targeted treatments, ... 标记为不相关
	CDC ACIP Workgroup Reviewing FDA-Approved HPV Vaccines - Contagion Live Contagion Live Among vaccinated women, the percentage of cervical pre-cancers caused by the HPV types most often linked to cervical cancer has dropped by 40%." 4. 标记为不相关
	The lipid-metabolic enzyme HSD17B12 drives lysosomal degradation of PD-L1 potentiating ... Research journals - PLOS ... lung carcinoma (NSCLC), renal cell carcinoma (RCC), breast cancer, and colorectal cancer (CRC). Despite these advances, the overall response rate ... 标记为不相关
	Comparing E-Health Nursing Interventions to Optimize Quality of Life in Oncology Care Cancer Nursing Today Lung Cancer · Skin Cancer · Other Tumor Types · News · Treatment. Menu Main Logo ... cancer, according to a recent meta-analysis. A team of ... 标记为不相关
	Sub-Q Daratumumab/VRd Wins Approval in Newly Diagnosed Multiple Myeloma Oncology Nursing News Heather Wenberg, BSN, RN, OCN, a regional director of nursing at the American Oncology Network, added in an interview with Oncology Nursing News that ... 标记为不相关
	Invasive Mucinous Adenocarcinoma Presenting as Cavitary Lung Disease: A Case Report ... The Cureus Journal of Medical Science Formerly classified as mucinous bronchioloalveolar carcinoma under the 2004 WHO system, it has since been redefined in the 2015 WHO classification as ... 标记为不相关
	Unraveling the PFOS-NSCLC Axis: Integrated Network Toxicolo gy, Machine Learning, and ... Frontiers ... lung cancer, perfluorooctane sulfonate (PFOS), Tumor immune microenvironment. Received: 24 Nov 2025; Accepted: 27 Jan 2026. Copyright: © 2026 Zhou ... 标记为不相关
查看更多结果 | 修改此快讯

您收到此电子邮件是因为您订阅了Google快讯。 退订 | 查看您所有的快讯

以RSS Feed的形式接收此快讯

发送反馈